![Ji-Won Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 30 482 $ al 31/08/2026
Ji-Won Kim currently works at Aju IB Investment Co., Ltd. (Private Equity), as Chief Executive Officer, AJU IB Investment Co., Ltd., as Chief Executive Officer & Director from 1999, and SL VaxiGen, Inc., as Director.
Mr. Kim received his undergraduate degree from Yonsei University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 10/06/2026 | 12.416 ( 0,01 % ) | 30 482 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| AJU IB INVESTMENT CO., LTD. | Director Ejecutivo | 01/01/1999 |
Aju IB Investment Co., Ltd. (Private Equity)
 Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB is a long-term investor focused on high technology Korean companies with significant growth potential. Aju IB's investment criteria include management's capability, ethics and transparency, potential market leadership or ability to control the market, technological barriers to entry, significant market size, profitability and maturity. They also take into consideration portfolio diversification. | Director Ejecutivo | - |
SL VaxiGen, Inc.
 SL VaxiGen, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures vaccine therapeutics | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Yonsei University
 Yonsei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aju IB Investment Co., Ltd. (Private Equity)
Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB is a long-term investor focused on high technology Korean companies with significant growth potential. Aju IB's investment criteria include management's capability, ethics and transparency, potential market leadership or ability to control the market, technological barriers to entry, significant market size, profitability and maturity. They also take into consideration portfolio diversification. | Finance |
AJU IB Investment Co., Ltd.
 AJU IB Investment Co., Ltd. Investment ManagersFinance Invests in venture and new technology businesses | Finance |
SL VaxiGen, Inc.
SL VaxiGen, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures vaccine therapeutics | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
